English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Pharmacogenomics studies the involvement of interindividual variations of DNA sequence in different drug responses (especially adverse drug reactions) Knowledge Discovery in Databases (KDD) process is a means for discovering new pharmacogenomic knowledge in biological databases However data complexity makes it necessary to guide the KDD process by representation of domain knowledge Three domains at least are in concern: genotype, drug and phenotype The approach described here aims at reusing whenever possible existing domain knowledge in order to build a modular formal representation of domain knowledge in pharmacogenomics The resulting ontology is called SO-Pharm for Suggested Ontology for Pharmacogenomics Various situations encountered during the construction process are analyzed and discussed A preliminary validation is provided by representing with SO-Pharm concepts some well-known examples of pharmacogenomic knowledge.

Suggested Ontology for Pharmacogenomics (SO-Pharm): Modular Construction and Preliminary Testing